AMYRIS TO PRESENT AT THE 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Amyris, a leading synthetic biotechnology company, will present at the 40th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amyris, a leading synthetic biotechnology company, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 11:15 am ET. This conference serves as a key platform for industry leaders, attracting significant attention from investors and analysts. A live webcast and replay of the presentation will be accessible on Amyris' Investor Relations page. The company focuses on sustainable ingredients in Clean Health & Beauty and Flavors & Fragrances, reaching over 300 million consumers.
Details
News Market Reaction – AMRS
The recorded move for AMRS in the trading session of this news was -9.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., Jan. 5, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 11:15 am ET.
A live webcast of the presentation and a replay will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ operating platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products.
Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301454301.html
SOURCE Amyris, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.